Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Murray

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Microbiology|August 1, 1991
Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteriaH D Isenberg, R F D'Amato, L Heifets, et al.
Journal of Clinical Microbiology|November 1, 1996
Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniaeJ H Jorgensen, J M Swenson, F C Tenover, et al.
Journal of Clinical Microbiology|April 1, 1992
Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacinA L Barry, M A Cohen, J C Sesnie, et al.
Cardiovascular Surgery (London, England)|March 12, 1999
Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response?M J Buckmaster, J A Curci, P R Murray, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Bone Marrow Transplantation|January 11, 2007
The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patientsS M Harrington, R S Buller, G A Storch, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesS A Marshall, R N Jones, P R Murray, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 19, 2008
Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related speciesC I Montero, Y R Shea, P A Jones, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Microbiology|August 1, 1991
Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteriaH D Isenberg, R F D'Amato, L Heifets, et al.
Journal of Clinical Microbiology|November 1, 1996
Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniaeJ H Jorgensen, J M Swenson, F C Tenover, et al.
Journal of Clinical Microbiology|April 1, 1992
Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacinA L Barry, M A Cohen, J C Sesnie, et al.
Cardiovascular Surgery (London, England)|March 12, 1999
Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response?M J Buckmaster, J A Curci, P R Murray, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Bone Marrow Transplantation|January 11, 2007
The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patientsS M Harrington, R S Buller, G A Storch, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesS A Marshall, R N Jones, P R Murray, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 19, 2008
Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related speciesC I Montero, Y R Shea, P A Jones, et al.
Pageof 15